MarketFriction

Vikas Lifecare Ltd

NSE VIKASLIFE · BSE 542655 · Trading & Distributors
₹1.20 -0.83%
NSE close2026-10-01
52 week range1.05 - 2.23
Market cap₹225 Cr.
P/E12.2
Price band 20% Delivery 51.6%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales9911699132921351181359214197169
Expenses961141041289213612115898259127195
Operating Profit32-54-0-1-3-23-6-118-30-26
OPM %2.7%2.0%-4.8%2.7%-0.3%-1.0%-2.7%-17%-6%-83%-31%-16%
Other Income1273-223-1211331165
Interest011111111222
Depreciation111112121221
Profit before tax138-3-10-1-7-5125-120-3335
Tax %9%2%28%222%9,833%-349%1%-46%0%-1%-12%-18%
Net Profit128-4-2-32-7-3125-119-2942
EPS in Rs0.080.05-0.02-0.01-0.020.01-0.04-0.020.67-0.64-0.160.22
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales75301476446480499
Expenses67302464442488616
Operating Profit8-1124-8-116
OPM %10%-0.3%2.5%0.9%-1.6%-23%
Other Income-344-28206136
Interest522357
Depreciation123476
Profit before tax-239-2117-137
Tax %133%26%-27%21%-15%-157%
Net Profit-429-1613-1118
EPS in Rs-0.030.26-0.110.09-0.060.10
Dividend Payout %0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%46%2%4%
Compounded Profit Growth%50%47%564%
Stock Price CAGR%-17%-39%-45%
Return on Equity%2%2%3%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital66110144165186186
Reserves090187311346366
Borrowings4223303477105
Other Liabilities41989344121103
Total Liabilities149321454555729760
Fixed Assets122847566136
CWIP000010
Investments3847718354394
Other Assets133208330316614330
Total Assets149321454555729760
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-8-15-112-42-222310
Cash from Investing Activity12-37-36-91106-334
Cash from Financing Activity-45915113710820
Net Cash Flow-0824-8-5
Free Cash Flow-9-28-130-51-234317
CFO/OP-90%1,565%-949%-1,045%2,905%-270%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3475213012097103
Inventory Days1563610844
Days Payable2168448134744
Cash Conversion Cycle2874921155462
Working Capital Days27012851418574
ROCE %19%-7%4%0%2%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters11.40%11.40%11.75%14.21%14.20%14.20%14.20%14.20%14.20%14.20%14.20%14.20%
FIIs0.02%0.02%4.35%0.28%0.50%0.49%0.46%0.38%0.30%0.28%0.26%0.26%
Public88.59%88.58%83.89%85.51%85.29%85.31%85.34%85.43%85.50%85.53%85.53%85.53%
No. of Shareholders5,44,4355,71,1667,29,3747,72,8867,92,5148,14,7848,20,2978,20,4058,10,0627,95,4997,81,1077,81,107

Fundamentals

Market Cap₹ 225 Cr.
Current Price₹ 1.21
Stock P/E12.2
Book Value₹ 2.97
ROCE2.16 %
ROE3.40 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)4%
Compounded Profit Growth (TTM)564%
Consolidated figures.
Valuation
Market capRs 133 Cr
Enterprise valueRs 148 Cr
P/E (TTM)7.21x
Price to book0.67x
Price to sales0.27x
EV / EBITDA7.56x
EV / EBIT10.85x
EV / sales0.30x
Earnings yield13.87%
Profitability
Operating margin (excl. other income)-0.31%
Operating margin (incl. other income)14.21%
EBITDA margin3.92%
Pre-tax margin1.43%
Net profit margin3.69%
Net margin, latest quarter24.65%
ROE21.57%
ROCE24.93%
ROA12.22%
ROIC (approx.)4.71%
Tax rate25.94%
Other income / net worth21.91%
Growth
Sales growth (latest year)301.28%
Sales growth QoQ73.78%
Sales growth YoY (latest quarter)24.72%
Per share
EPS (TTM)Rs 0.17
EPS (latest year)Rs 0.26
EPS (latest quarter)Rs 0.38
Book value per shareRs 1.80
Sales per shareRs 4.52
Cash flow per shareRs -0.13
Free cash flow per shareRs 2.87
Efficiency
Asset turnover0.94x
Fixed asset turnover10.73x
Inventory turnover10.22x
Inventory days36 days
Debtor days52 days
Debtors turnover7.04x
Creditor days44 days
Cash conversion cycle62 days
Working capital days74 days
Leverage
Total debtRs 23 Cr
Cash and bankRs 8 Cr
Net debtRs 15 Cr
Debt to equity0.12x
Net debt / EBITDA0.79x
Interest coverage2.09x
Owners' fund to total sources62.17%
Debt to assets7.20%
Cash flow
Cash from Operating Activity (latest year)Rs -15 Cr
Cash from Investing Activity (latest year)Rs -37 Cr
Cash from Financing Activity (latest year)Rs 59 Cr
Net Cash Flow (latest year)Rs 8 Cr
Free cash flow (latest year)Rs 317 Cr
FCFE (approx.: FCF + change in debt)Rs 298 Cr
Cash from ops / profit, 5 years-2.45x
Statement figures
Net sales (TTM)Rs 499 Cr
Net sales (latest year)Rs 301 Cr
Sales (latest quarter)Rs 169 Cr
Operating profit excl. other income (latest year)Rs -1 Cr
Operating profit (latest quarter)Rs -26 Cr
Other income (TTM)Rs 199 Cr
EBITDA (TTM)Rs 20 Cr
PBDT (TTM)Rs 13 Cr
Profit before tax (TTM)Rs 7 Cr
Tax (latest year)Rs 10 Cr
Net profit (TTM)Rs 18 Cr
Net profit (latest year)Rs 29 Cr
Net profit (latest quarter)Rs 42 Cr
Depreciation (TTM)Rs 6 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 7 Cr
Cost of goods sold (latest year)Rs 291 Cr
Total expenditure (latest year)Rs 302 Cr
Total income (latest year)Rs 345 Cr
Share capitalRs 110 Cr
ReservesRs 90 Cr
Shareholders' fundsRs 199 Cr
Total assetsRs 321 Cr
Net blockRs 28 Cr
InvestmentsRs 84 Cr
ReceivablesRs 43 Cr
InventoryRs 28 Cr
Other liabilitiesRs 98 Cr
Shares outstanding (crore)110.58
Ownership
Promoter holding14.20% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodVIKASLIFENifty 50Difference
1 week-3.2%-2.8% -0.4 pts
1 month-4.0%-6.8% +2.8 pts
3 months-17.2%-7.6% -9.6 pts
6 months+13.2%+0.4% +12.8 pts
1 year-45.7%-9.9% -35.8 pts
2 years-72.8%-13.6% -59.2 pts
3 years-77.6%+14.2% -91.7 pts
5 years-64.7%+27.9% -92.6 pts

Red flags

F-score 5 of 8
explainWeak cash conversion Cash from operations was -90% of net profit over the last 2 years
explainHigh accruals Profit exceeded operating cash by 14% of total assets in 2026
lookProfit leans on other income Other income was 112% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹169 Cr +25.2% vs Mar 2025. Net profit ₹42 Cr +1500.0%.
Against our estimate for Mar 2026: sales +34.1%, profit +307.6% beat. Our estimate for Jun 2026: sales Rs 95 Cr, profit Rs -2 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Redington Ltd31,69717.618.4 %
MMTC Ltd8,51442.38.67 %
MSTC Ltd5,02821.530.3 %
BN Agrochem Ltd1,8981114.44 %
Creative Newtech Ltd1,64622.318.8 %
Pervasive Commodities Ltd1,04922.1 %
RRP Defense Ltd843-11.1 %
Yamuna Syndicate Ltd7848.564.17 %
Shiv Aum Steels Ltd74277.98.20 %
State Trading Corporation of India Ltd64413.3%
Arvaya Healthcare Ltd600451%
SMT Engineering Ltd59624.325.4 %
HP Telecom India Ltd52820.719.9 %
Riddhi Siddhi Gluco Biols Ltd52737.22.74 %
Oswal Agro Mills Ltd4742.03 %
No bulk or block deals on record.
Ex-dateActionFactor
2024-09-23Annual General Meeting
2023-09-22Annual General Meeting
2022-09-21Annual General Meeting
2021-10-29 Rights 4:21 @ Premium Rs 1.80/-
2021-09-09 Annual General Meeting
2021-05-20 Rights 2:5 @ Premium Re 0.85/-
2020-09-22 Annual General Meeting
DateTypeWhat it says
2026-09-17General UpdatesIntimation of approval for extension of time for holding Annual General Meeting (AGM) for the financial year ended March 31, 2026
2026-09-08General UpdatesGeneral Updates
2026-08-10Reply to Clarification- FinaThe Exchange had sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing...
2026-07-31Clarification - Financial ReThe Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing...
2026-07-17Clarification - Financial ReThe Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing...
2026-07-15General UpdatesGeneral Updates
2026-07-09Board meeting outcomeVikas Lifecare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-06-27General UpdatesNewspaper Advertisement for Financial Results quarter and year ended March 31, 2026
2026-06-25Clarification - Financial ReThe Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing...
2026-06-24Board meeting outcomeOutcome of Board Meeting held on 24th June, 2026
2026-06-23General UpdatesDisclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015
2026-06-12Disclosure under SEBI TakeovVikas Garg has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquis...
2026-05-19Shareholder meetingVoting results.
2026-05-18Shareholder meetingVoting results.
2026-04-25General UpdatesNewspaper Advertisement of Un-Audited Financial Results of the Company for the Quarter ended September 30, 2025 and Quarter and Nine Months ended Dece...
2026-04-22Board meeting outcomeVikas Lifecare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
2026-04-22Board meeting outcomeVikas Lifecare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
2026-04-22Board meeting outcomeVikas Lifecare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-04-22Board meeting outcomeVikas Lifecare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-04-15Shareholder meetingNotice of Postal Ballot
2026-04-14Committee Meeting UpdatesOutcome of Committee Meeting held on April 14, 2026.
2026-04-14General UpdatesDisclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015Receipt of Income Tax Demand Order(s)
2026-04-11Disclosure of material issueVikas Lifecare Limited has informed regarding Disclosure of material issue i.e. Fund Raising and other matters
2026-04-11Board meeting outcomeOutcome of Board Meeting held on April 11, 2026.
2026-04-06General UpdatesCertificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter end...
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
EPS in the scrip is zero (4 trailing quarters)

Quick answers

What is the market cap of Vikas Lifecare Ltd?

Vikas Lifecare Ltd (VIKASLIFE) has a market capitalisation of Rs 225 Cr. at the 2026-10-01 close.

What is the P/E ratio of Vikas Lifecare Ltd?

Vikas Lifecare Ltd trades at a P/E of 12.2 on trailing twelve-month profit, at the 2026-10-01 close.

What were Vikas Lifecare Ltd's latest quarterly results?

In the Mar 2026 quarter, Vikas Lifecare Ltd sales was Rs 169 Cr (+25.2% vs Mar 2025) and net profit was Rs 42 Cr.

What is the 52-week high and low of Vikas Lifecare Ltd?

The 52-week high is Rs 2.23 and the 52-week low is Rs 1.05.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03